Little Green Pharma Ltd
ASX:LGP
Little Green Pharma Ltd
ASX:LGP
Price:
0.11
AUD
-4.35%
Market Closed
Market Cap:
AU$33.6m
Income Statement
Earnings Waterfall
Little Green Pharma Ltd
Little Green Pharma Ltd
Income Statement
Little Green Pharma Ltd
Little Green Pharma Ltd
Currency: AUD
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Revenue |
2
N/A
|
5
+139%
|
7
+33%
|
11
+51%
|
16
+56%
|
20
+21%
|
23
+17%
|
26
+10%
|
31
+19%
|
37
+20%
|
38
+5%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(1)
|
(2)
|
(3)
|
(5)
|
(10)
|
(10)
|
(11)
|
(12)
|
(11)
|
(12)
|
(13)
|
|
| Gross Profit |
1
N/A
|
3
+152%
|
4
+50%
|
5
+22%
|
7
+33%
|
10
+47%
|
12
+17%
|
14
+15%
|
19
+41%
|
24
+27%
|
26
+6%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(9)
|
(8)
|
(10)
|
(19)
|
(26)
|
(22)
|
(18)
|
(22)
|
(29)
|
(28)
|
(28)
|
|
| Selling, General & Administrative |
(8)
|
(7)
|
(8)
|
(11)
|
(15)
|
(16)
|
(13)
|
(16)
|
(23)
|
(24)
|
(24)
|
|
| Research & Development |
(1)
|
(1)
|
(2)
|
(9)
|
(12)
|
(7)
|
(5)
|
(6)
|
(4)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(4)
|
(4)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Operating Income |
(8)
N/A
|
(5)
+31%
|
(6)
-10%
|
(14)
-149%
|
(19)
-35%
|
(12)
+37%
|
(6)
+53%
|
(9)
-50%
|
(9)
-9%
|
(4)
+57%
|
(2)
+49%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(3)
|
(1)
|
(0)
|
(1)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
1
|
25
|
26
|
3
|
(0)
|
(2)
|
(1)
|
0
|
(0)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
2
|
3
|
3
|
3
|
5
|
5
|
1
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(3)
+64%
|
22
N/A
|
13
-41%
|
(16)
N/A
|
(9)
+47%
|
(3)
+63%
|
(8)
-160%
|
(10)
-17%
|
(5)
+50%
|
(2)
+53%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
|
| Income from Continuing Operations |
(9)
|
(3)
|
22
|
13
|
(16)
|
(9)
|
(3)
|
(8)
|
(10)
|
3
|
6
|
|
| Net Income (Common) |
(9)
N/A
|
(3)
+64%
|
22
N/A
|
13
-41%
|
(16)
N/A
|
(9)
+44%
|
(4)
+61%
|
(8)
-129%
|
(9)
-16%
|
3
N/A
|
6
+76%
|
|
| EPS (Diluted) |
-0.07
N/A
|
-0.03
+57%
|
0.13
N/A
|
0.05
-62%
|
-0.07
N/A
|
-0.03
+57%
|
-0.01
+67%
|
-0.03
-200%
|
-0.03
N/A
|
0.01
N/A
|
0.02
+100%
|
|
Switch to:
Switch to:
See Also
Discover More
